Imagen de Portada

Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autor principal:	Sandra L. Kane‐Gill
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Incidence of Acute Kidney Injury With the Use of Nafcillin Versus Oxacillin
por: Alejandro D. Perez, et al.
Publicado: (2026)

Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam
por: Maryam Ramazani, et al.
Publicado: (2025)

SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
por: Erin F. Barreto, et al.
Publicado: (2026)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
por: Yi‐Fan Chien, et al.
Publicado: (2025)

Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on Proteinuria in Kidney Transplant Recipients
por: Stephanie Shabanowitz, et al.
Publicado: (2026)

Hyperfiltration in Critically Ill Older Adults: Incidence, Risk Factors, Time Course, and Predictive Performance of Kidney Function Estimation
por: Ryusei Mikami, et al.
Publicado: (2026)

Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
por: Eugene Jeong, et al.
Publicado: (2025)

Response to Comment on “Acute Pharmacodynamic Effects of Oral Levodopa on Blood Pressure in Parkinson’s Disease”
por: Katherine Longardner, et al.
Publicado: (2026)

In Search of Big Beautiful Biomarkers
por: C. Lindsay DeVane
Publicado: (2025)

Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
por: William L. Baker, et al.
Publicado: (2026)

Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
por: Youjun Chen, et al.
Publicado: (2025)

Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
por: Amy Broadwater, et al.
Publicado: (2026)

Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
por: Amira R. Rashdan, et al.
Publicado: (2026)

Correction to Chloride Dipstick to Rapidly Estimate Urine Sodium During Diuresis in Acute Heart Failure
Publicado: (2025)

Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
por: Aya M. AbdelMagid, et al.
Publicado: (2026)

Disease‐modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medications
por: Erika L. Hellenbart, et al.
Publicado: (2024)

Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
por: Yaping Zhan, et al.
Publicado: (2025)

DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
por: Alfred Zheng Ting Ho, et al.
Publicado: (2026)

Pharmacokinetics of Sulbactam/Durlobactam in a Patient With Acute Renal Failure, Severe Obesity, and Carbapenem‐Resistant Acinetobacter baumannii Bacteremia: A Case Report
por: Dan Ilges, et al.
Publicado: (2025)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
por: Maryam Aghakouchakzadeh, et al.
Publicado: (2026)

A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
por: Kathleen A. Stringer, et al.
Publicado: (2025)

Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
por: Wenqiang Zhou, et al.
Publicado: (2026)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
por: Jiwon Kim, et al.
Publicado: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
por: Amanda Massmann, et al.
Publicado: (2025)

Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
por: Jyotirmoy Sarker, et al.
Publicado: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
por: Lisa T. Hong, et al.
Publicado: (2024)

Intraperitoneal Granisetron for Post‐Laparoscopic Cholecystectomy Pain Management: A Double‐Blinded, Randomized Controlled Trial
por: Hoda Mohamed Bayoumi, et al.
Publicado: (2025)

Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
por: Saurabh Rahurkar, et al.
Publicado: (2025)

Assessment of Artificial Intelligence ( AI )‐Powered Self‐Care Recommendations for Management of Minor Ailments: A Comparative Analysis
por: Sham ZainAlAbdin, et al.
Publicado: (2025)

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
por: Zachary P. Brehm, et al.
Publicado: (2025)

Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Publicado: (2025)

Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Publicado: (2024)

Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
por: Daniela Gorski, et al.
Publicado: (2025)

C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?
por: Nicoline Bihelek, et al.
Publicado: (2025)

Comment on “C‐Reactive Protein and Neutrophil‐to‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?”
por: Yuki Kikuchi
Publicado: (2026)

Cost‐Effectiveness Analysis of Patient Self‐Management of Warfarin Among Patients With Non‐Valvular Atrial Fibrillation
por: Warittakorn Kategeaw, et al.
Publicado: (2026)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
por: Candice L. Garwood, et al.
Publicado: (2024)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
por: Elizabeth M. Sherman, et al.
Publicado: (2024)

Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
por: Casey L. Keller, et al.
Publicado: (2026)